Previous Article | Next Article 
Journal of Virology, April 2001, p. 3819-3831, Vol. 75, No. 8
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.8.3819-3831.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Human Neuron-Committed Teratocarcinoma NT2 Cell
Line Has Abnormal ND10 Structures and Is Poorly Infected by Herpes
Simplex Virus Type 1
Wei-Li
Hsu and
Roger D.
Everett*
MRC Virology Unit, Institute of Virology,
University of Glasgow, Glasgow G11 5JR, Scotland, United Kingdom
Received 12 October 2000/Accepted 17 January 2001
 |
ABSTRACT |
Herpes simplex virus type 1 (HSV-1) immediate-early regulatory
protein ICP0 stimulates the initiation of lytic infection and reactivation from quiescence in human fibroblast cells. These functions
correlate with its ability to localize to and disrupt centromeres and
specific subnuclear structures known as ND10, PML nuclear bodies, or
promyelocytic oncogenic domains. Since the natural site of herpesvirus
latency is in neurons, we investigated the status of ND10 and
centromeres in uninfected and infected human cells with neuronal
characteristics. We found that NT2 cells, a neuronally committed human
teratocarcinoma cell line, have abnormal ND10 characterized by low
expression of the major ND10 component PML and no detectable expression
of another major ND10 antigen, Sp100. In addition, PML is less
extensively modified by the ubiquitin-like protein SUMO-1 in NT2 cells
compared to fibroblasts. After treatment with retinoic acid, NT2 cells
differentiate into neuron-like hNT cells which express very high levels
of both PML and Sp100. Infection of both NT2 and hNT cells by HSV-1 was
poor compared to human fibroblasts, and after low-multiplicity
infection yields of virus were reduced by 2 to 3 orders of magnitude.
ICP0-deficient mutants were also disabled in the neuron-related cell
lines, and cells quiescently infected with an ICP0-null virus could be
established. These results correlated with less-efficient disruption of
ND10 and centromeres induced by ICP0 in NT2 and hNT cells. Furthermore, the ability of ICP0 to activate gene expression in transfection assays
in NT2 cells was poor compared to Vero cells. These results suggest
that a contributory factor in the reduced HSV-1 replication in the
neuron-related cells is inefficient ICP0 function; it is possible that
this is pertinent to the establishment of latent infection in neurons
in vivo.
 |
INTRODUCTION |
Herpes simplex virus type 1 (HSV-1)
is an important human pathogen which causes recurrent infections in
epithelia between long periods of latency in neuronal cells (23,
58). The basis of the differences between lytic infection (which
involves active and abundant transcription from the whole viral genome)
and latency (a state of transcriptional quiescence of the bulk of the
genome) has been the subject of intense research. There is now a wealth of information on the lytic transcriptional program of HSV-1 and the
viral regulatory proteins which stimulate viral gene expression, but
less is known about the difference in host cell functions which might
contribute to the differing outcomes of infection in neuronal and
non-neuronal cells.
One aspect of host cell biology which has become of interest in recent
years and which could conceivably modulate HSV-1 infection is the
function and status of small nuclear substructures known as ND10, PML
nuclear bodies, or promyelocytic oncogenic domains (11, 37, 38,
53). At the early stages of infection, the parental genomes of
HSV-1 and several other DNA viruses preferentially localize in the
vicinity of ND10. It has been demonstrated that transcription of viral
immediate-early (IE) genes occurs at these sites, from which viral
replication centers later originate (26, 36). Many DNA
viruses encode regulatory proteins that interact directly with ND10,
first colocalizing with the cellular protein constituents and then
disrupting these structures. This is especially well understood in the
case of HSV-1 regulatory protein ICP0, which disrupts both ND10 and
centromeres by inducing the proteasome-dependent degradation of several
of their constituent proteins (12, 37, 38). HSV-1 mutants
that do not express active ICP0 have a marked defect in the ability to
initiate the lytic cycle after low-multiplicity infection and instead
are likely to enter a quiescent state in which all viral transcription
is silenced. A number of studies have demonstrated that the ability of
ICP0 to affect ND10 and centromeres is concordant with its ability to
stimulate virus infection, so it has been proposed that degradation of
at least one of the known cellular targets of ICP0, or the mechanism by which this occurs, is an important factor in the balance between active
and quiescent infection (12). This background led us to
investigate the status of ND10 in neuron-like cells.
A number of previous studies have used neuronal cells of various
origins. Rat and mouse neuroblastoma cell lines that can be
differentiated into a neuron-like morphology have been found to be
poorly infected by HSV-1 (56, 57). This defect has been attributed to poor IE gene transcription (29) and can be
overcome in part by treatment with butyrate (1, 28) or
release of the cells from growth arrest (47). It has been
suggested that poor IE transcription in neuronal cells is caused by the
repressive effects of Oct-2 transcription factors which bind to the
TAATGARAT IE regulatory elements, thereby inhibiting Oct-1- and
VP16-mediated transactivation (33, 34), but these studies
have remained controversial (24). Whatever the mechanism
of repression, the result is that it is possible to establish cultures
of rodent neuron-like cells that harbor quiescent HSV-1 genomes for
long periods (2, 56). Experiments with neurons explanted
from rat embryonic dorsal root ganglia have extended these studies and
demonstrated that in these true neuronal cells long-term quiescent infections can be established and used to investigate the processes controlling viral quiescence and reactivation (51, 59).
Rodent cells are not amenable to examination of their ND10 structures
since most of the available antibodies recognize only the human forms
of the major constituent proteins. Therefore, we sought to use a
suitable human neuron-related cell line for our experiments. Human
neuroblastoma cell lines have been used in a number of HSV-1 infection
studies. Such cells are permissive for viral replication after
high-multiplicity infection (4, 5), and the use of
infection at supra-optimal temperatures has allowed the establishment
of quiescently infected cultures which can later be reactivated
(31). We chose to study the well-characterized neuronally committed teratocarcinoma NT2 cells which grow well in
culture but can be differentiated into neuron-like hNT cells after
treatment with retinoic acid (41, 42). NT2 cells are permissive for high-multiplicity HSV-1 infection (30), but
low-multiplicity infections and the influence of ICP0 have not been
analyzed in these cells. It had previously been noted that NT2 cells
express low amounts of the major ND10 protein PML (32) and
that Sp100 (another major ND10 constituent) appeared to be absent
(27), but the fate of these proteins during
differentiation and HSV-1 infection had not been studied.
The aims of this study were severalfold. We set out to investigate in
detail the status of ND10 in both NT2 and hNT cells and to monitor the
fate of ND10 and the major constituent proteins during HSV-1 infection.
We also studied the ability of HSV-1 to infect both NT2 and hNT cells,
and we assessed the role of ICP0 in these infections. Finally, we
characterized the ability of ICP0 to affect ND10 proteins, to stimulate
virus infection, and to activate gene expression in these cell lines.
Our results demonstrate that ND10 are highly aberrant in NT2 cells but
become more like those in other cultured cells after differentiation.
HSV-1 replicated with reduced efficiency in both cell lines, especially
in low-multiplicity infections, and this correlated with a reduced
ability of ICP0 to disrupt ND10 and centromeres. Finally, we found that
ICP0-deficient viruses can attain a quiescent state in infected NT2 and
hNT cells and can be subsequently reactivated by superinfection with
viruses which express ICP0. These results suggest that NT2 and hNT
cells provide a promising system in which to study HSV-1 infection in neuron-related cultured cells of human origin.
 |
MATERIALS AND METHODS |
Cells and cell culture.
The Ntera 2/D1 (NT2) cell line was
obtained from Stratagene and was grown in Dulbecco's modified Eagle
medium (DMEM) with nutrient mixture F12 (Gibco), supplemented with 4 mM
glutamine, 10% fetal calf serum (FCS), and 100 U of penicillin and 100 µg of streptomycin per ml. Differentiation of NT2 cells into the neuronal phenotype hNT cells was done according to the supplier's protocol. Briefly, 106 NT2 cells were seeded into
25-cm2 flasks with 5 ml of medium containing 10 µM
all-trans-retinoic acid (ATRA). The culture medium was changed three
times per week for 6 weeks, and then the cells were transferred to a
75-cm2 flask in medium without ATRA and cultured for an
additional 2 days. The loosely adherent hNT cells were then recovered
in the culture medium by striking the flask sharply, resulting in a
population of cells with more than 30% having a significant neuronal
morphology, and all the recovered hNT cells expressed high levels of
Sp100 (see below).
Baby hamster kidney (BHK) cells were used for the propagation and
titration of virus stocks, and were grown in Glasgow modified Eagle
Medium containing antibiotics as described above and supplemented with
10% newborn calf serum (NBCS) and 10% tryptose phosphate broth. HEp-2
and Vero cells were grown in DMEM supplemented with 10% FCS and
antibiotics as described above. Human fetal lung (HFL) diploid
fibroblast cells (Imperial Laboratories) and U2OS cells were propagated
in DMEM supplemented with 5% FCS, 5% NBCS, 1% nonessential amino
acids (Gibco), and antibiotics as described above.
Viruses.
HSV-1 strain 17+ was the wild-type virus used in
these experiments, from which the ICP0-null mutant virus
dl1403 had been derived (54). Other viruses
with lesions in ICP0 were the RING finger deletion mutant FXE
(10) and virus M1, which has point mutations in the USP7
binding region (21). Virus tsK contains a
temperature-sensitive mutation in ICP4, which results in failure to
activate early and late gene expression and high level production of
the other IE proteins at the nonpermissive temperature of 38.5°C (44). Virus in1330 carries a human
cytomegalovirus (HCMV) lacZ cassette inserted into UL43, the
ICP4 tsK mutation, and a deletion in the ICP0 coding region
inducing a frameshift in codon 105 (25).
Antibodies.
The following antibodies were used: anti-ICP0
monoclonal antibody (MAB) 11060 (16) and anti-ICP0
polyclonal rabbit serum r190 (19), anti-ICP4 MAB 10176 (15), anti-UL39 rabbit serum r76 (6),
anti-UL42 MAB Z1F11 (50), anti-UL29 rabbit serum r515
(35), anti-PML rabbit serum r8 (3), and
anti-PML MAB 5E10 (55), anti-Sp100 polyclonal rabbit serum
SpGH (52), anti-hDaxx rabbit serum r1866
(43), anti-CENP-C rabbit serum r554 (48), and
human anti-centromere autoimmune serum GS (ACA-GS) (7). Anti-
-galactosidase rabbit serum r12741/2 was a gift from Howard Marsden. Secondary antibodies for immunofluorescence were used at the
indicated dilutions: fluorescein isothiocyanate-conjugated sheep
anti-rabbit immunoglobulin G (IgG; 1/100; Sigma), Cy3-conjugated goat
anti-mouse IgG (1/500) and goat anti-rabbit IgG (1/5,000), and
Cy5-conjugated goat anti-rabbit IgG (1/500) (Amersham). Horseradish peroxidase-conjugated sheep anti-mouse and goat anti-rabbit secondary antibodies for use in Western blotting were obtained from Sigma.
Immunofluorescence.
Cells were seeded onto coverslips in
Linbro wells at a density of 105 cells per well 1 day prior
to infection or transfection. After appropriate infection or
transfection, cells were fixed with formaldehyde (5% [vol/vol] in
phosphate-buffered saline [PBS] containing 2% sucrose) and then
permeabilized with 0.5% NP-40 in PBS with 10% sucrose. The primary
antibodies were diluted in PBS containing 1% NBCS. Antibodies were
used at the following dilutions: 11060, 1/1,000; r8, 1/1,000; r190,
1/200; r515, 1/200; SpGH, 1/1,000; r1866, 1/1,000; ACA-GS, 1/20,000;
and r12741/2, 1/1,000. After incubation at room temperature for 1 h, the coverslips were washed at least six times and then treated with
secondary antibodies. After a further 60-min incubation, the coverslips
were again washed at least six times and mounted using Citifluor AF1.
Confocal microscopy.
Samples were examined using 543-nm and
488-nm excitation lasers of a Zeiss LSM 510 confocal microscope (a
Zeiss Axioplan with a ×63 oil immersion objective lens, NA 1.4). The
data from the channels were collected sequentially using the
appropriate band-pass filters built into the instrument. The scanning
conditions were adjusted to ensure that signal overlap between channels
was essentially eliminated. Data were collected with fourfold averaging
at a resolution of 1,024 × 1,024 pixels using optical slices of
between 0.5 and 1 µm. Data sets were processed using the LSM 510 software and then exported for preparation for printing using Photoshop.
Western blotting.
Sodium dodecyl sulfate-polyacrylamide gels
were prepared and run in the Bio-Rad MiniProtean II apparatus, and then
the proteins were electrophoretically transferred to nitrocellulose
membranes according to the manufacturer's recommendations. After a
blocking step in PBS containing 0.1% Tween 20 (PBST) and 5% dried
milk overnight at 4°C, the membranes were incubated with primary
antibody in PBST-5% dried milk at room temperature for 4 h and
then washed in PBST at least six times before incubation with
horseradish peroxidase-conjugated secondary antibody in PBST-2% dried
milk at room temperature for 1 h. After an extensive washing, the
filters were soaked in Amersham or NEN Enhanced ECL reagent and exposed to film. Antibodies were stripped from the membranes following the
Amersham ECL protocol, and the membranes were reprobed as necessary.
Plasmids, transfection of cultured cells, and CAT assays.
The following plasmids were used for transfection assays: pCI110
(21), pSS80 (18), p175 (9),
pCIPIC1 (20), and pgDCAT (8). Plasmid
pCI-rtag-cICP0 contains the ICP0 cDNA coding region linked to an
N-terminal oligonucleotide encoding an epitope from the C terminus of
UL30, inserted into the expression vector pCIneo (Promega). Plasmids
were transfected into Vero and NT2 cells using Lipofectamine Plus
reagent (Gibco-BRL) using 0.5 µg of total DNA and 1 µl of reagent
per 105 cells. For chloramphenicol acetyltransferase (CAT)
assay transfections, 10 ng of pSS80 reporter was used, and plasmid pUC9
was used to equalize the total amounts of DNA; the amount of the ICP0
expression plasmid varied between 5 and 500 ng (see Fig. 7).
Transfected cells were fixed and stained for immunofluorescence,
harvested for Western blotting, or used to prepare CAT assay extracts
about 24 h later. The ability of ICP0 to activate gene expression
in transfected cells was determined using reporter plasmids pSS80 and
pgDCAT, which contain the CAT gene linked to the HSV-1 ICP6 and
glycoprotein gD gene promoter regions, respectively. Cells in Linbro
wells were transfected as described above, and then whole sonicated
cell extracts were prepared and used for estimation of CAT activity
using radiolabeled chloramphenicol as substrate, essentially as
described elsewhere (8). Initial experiments determined
the optimal amounts of reporter and activator plasmids to be used in
each cell type. The transfection experiments were repeated on several
independent occasions in parallel with positive and negative controls.
 |
RESULTS |
Neuronal committed teratocarcinoma NT2 cells have highly abnormal
ND10.
The first stage of this project was to compare the
composition and morphology of ND10 in neuronal committed NT2 and
fibroblast HFL cells. Double staining for the major ND10 antigens PML
and Sp100 showed the normal extensive colocalization of the two
proteins in multiple punctate nuclear foci in HFL cells, but the
overwhelming majority of NT2 cells had only background levels of Sp100
(27) and fewer PML foci (Fig.
1A). The distribution of PML was
unusual in many NT2 cells, commonly with strings,
tracks or lines of small foci extending through the nucleoplasm. One of
the NT2 cells shown in Fig. 1 has two moderate examples of this
phenotype, but many others had PML tracks similar to those in the hNT
cells shown in Fig. 1A. In HFL cells, the PML-associated protein hDaxx
(27) was present throughout the nucleus and in local
accumulations which in many cases strongly colocalized with PML (Fig.
1A). In contrast, in NT2 cells hDaxx was much less well associated with PML (Fig. 1A) and the distinct accumulations of hDaxx were instead preferentially associated with centromeres (Fig. 1B). This is reminiscent of recent data which showed that hDaxx can be present at
both ND10 and centromeres, and its relative association with these
structures can be influenced by cell status (22). In
contrast to the abnormal ND10, the staining pattern of centromere
protein CENP-C in NT2 cells was similar to that in HFL cells (Fig. 1A).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 1.
Distinct expression patterns of ND10 and centromere
proteins in HFL, NT2, and hNT cells. Confocal micrographs of the three
cell lines are presented, as indicated by white lettering. (A) The
labeled proteins are indicated in the top row and are the same in each
vertical row of panels. PML was stained with mouse MAb 5E10 (green),
and the cells were also costained with SpGH (lefthand panels), rabbit
serum r1866 (center panels), or rabbit serum r554 (righthand panels)
for Sp100, hDaxx, and CENP-C, respectively. There is no Sp100
expression and less PML expression in NT2 cells, and PML does not
colocalize efficiently with hDaxx. In HFL and hNT cells, PML
extensively colocalizes (yellow) with Sp100 and hDaxx but not with
CENP-C. (B) Localization of hDaxx (green) and centromere proteins
(red). Cells were double labeled with r1866 and human serum ACA-GS
which contains antibodies against several centromere proteins. In NT2
cells, a significant proportion of centromeres are associated with
local accumulations of hDaxx, but this occurs more rarely in HFL and
hNT cells.
|
|
In confirmation of the results of Ishov et al. (
27),
Western blotting of whole-cell extracts of NT2 compared to HFL cells
confirmed that NT2 cells contained negligible amounts of Sp100
(Fig.
2). We also found that NT2 cells
contained comparatively
low amounts of PML and the proportion of PML
that was modified
by the small ubiquitin-like protein SUMO-1 was
apparently much
reduced in NT2 compared to HFL cells (Fig.
2). It is
likely that
the relatively poor association of hDaxx with PML detected
by
fluorescence (Fig.
1A) can be explained by the less extensively
SUMO-1-modified PML in NT2 cells (Fig.
2) because hDaxx interacts
with
PML only when the latter is SUMO-1 modified (
27).

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 2.
Western blot analysis of the expression patterns of
Sp100 and PML in HFL, NT2, and hNT cells. The lefthand three tracks
show PML species detected by 5E10, with actin detected simultaneously
as the internal control. The righthand three lanes show the same filter
after stripping and reprobing for Sp100 with SpGH. The arrowheads mark
the presumed SUMO-1-modified forms of PML and Sp100. NT2 cells do not
express Sp100, whereas in hNT cells long-term induction of retinoic
acid results in a drastic increase of both unmodified and modified
forms of Sp100 and PML. The extent of SUMO-1 modification of PML is
reduced in NT2 cells.
|
|
Differentiation of NT2 cells into neuron-like hNT cells restores
ND10 structure.
NT2 cells can be induced to differentiate into
nondividing hNT cells by treatment with retinoic acid for several weeks
(41). The resultant hNT cells acquire a neuron-like
morphology and express a number of neuron-specific markers
(42). Staining of hNT cells for PML and Sp100 revealed
that, in great contrast to the parental NT2 cells, hNT cells have
striking ND10 with prominent foci of both proteins colocalizing
precisely (Fig. 1A). Again, tracks or chains of small beads of PML were
common. A further difference between NT2 and hNT cells was that in the
latter hDaxx was strongly associated with PML (Fig. 1A) and much less
well associated with centromeres (Fig. 1B). These data correlate with
strikingly increased amounts of both Sp100 and PML, and particularly
SUMO-1-modified PML, in hNT cells (Fig. 2). Since hDaxx does not
interact with Sp100 (27), this result strengthens the
conclusion that the distribution of hDaxx is dependent on PML and its
modification. Thus, either ATRA itself or the process of
differentiation induces substantial changes in the quantities of PML
and Sp100 present in the cells, with consequent alterations in ND10
appearance and composition. Our previous examination of the precursor
NT2 cells had found occasional cells with prominent ND10 containing
both PML and Sp100 (data not shown), and it is likely that these cells represent the small number of cells which are known to undergo spontaneous differentiation in NT2 cultures. Time course experiments showed that the increased amounts of Sp100 appeared after at least 3 weeks of treatment with retinoic acid, which implies that these changes
result from the process of differentiation rather than from a simple
induction of PML and Sp100 transcription by retinoic acid.
HSV-1 replicates poorly in NT2 and hNT cells.
As detailed in
the introduction, previous work found that HSV-1 has a growth defect,
particularly in low-multiplicity infections, in rodent neuroblastoma
cell lines or cells which could be differentiated into a neuron-like
state. Equivalent studies on HSV-1 infection of human neuroblastoma
cell lines had not investigated low-multiplicity infections in any
detail, and there was no information on the requirement for and
functionality of ICP0 in such cells. Therefore, we compared the
efficiency of HSV-1 replication in HFL and NT2 cells. An initial time
course experiment using a multiplicity of 1 PFU per cell showed that
the virus replicated slightly more slowly in NT2 cells than in HFL
cells, but by 36 h the yield of virus was only moderately reduced.
Extending the incubation period to 48 h did not significantly
alter the results from those obtained at 36 h (Fig.
3). A series of parallel infections were
conducted on NT2 and HFL cells at multiplicities varying from 50 to
0.01 PFU per cell, and the progeny virus was harvested and titrated 36 h later. This length of incubation allows multiple rounds of viral replication in HFL cells, so the final yields were not
significantly affected by input multiplicity in this cell type (Table
1). In contrast, at an input multiplicity
of 0.01, the yield of virus was reduced 400-fold in NT2 compared to HFL
cells (Table 1). Similar results were obtained after extending the
incubation period to 48 h, which indicates that the defect cannot
be explained simply by delayed kinetics (Table
2). Comparison of NT2 and hNT cells in
parallel experiments demonstrated that HSV-1 17+ replicated slightly
less well in the differentiated cells at all multiplicities, but the
differences between NT2 and hNT cells were small compared to those
between NT2 and HFL cells (Table 1). We attempted to compare the
plating efficiency of the virus in the three cell lines but, because of
the poor growth in NT2 and hNT cells, plaque formation on these cells
was too poor to be scored.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 3.
Growth curves of HSV-1 strain 17+ in HFL and NT2 cells.
Cells were infected with the virus at 1 PFU per cell, and both cells
and medium were harvested at the indicated times after infection;
progeny virus titers were then determined on BHK cells. The data are
the average of two independent experiments.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Efficiency of replication of HSV-1 strain 17+ and ICP0
mutants dl1403 and M1 in HFL, NT2, and hNT
cellsa
|
|
ICP0-deficient mutants also replicate poorly in NT2 and hNT
cells.
Next, we compared the growth efficiencies in HFL and NT2
cells of ICP0-null mutant virus dl1403 and the USP7-binding
negative mutant M1. Deletion dl1403 has been characterized
as having a severe multiplicity-dependent growth defect in HFL cells
(54), while the interaction with the ubiquitin-specific
protease USP7 was found to contribute to ICP0 function in BHK cells and
to a lesser extent in HFL cells (13, 21). To compare the
yields of these viruses in the various cell types, we first determined the titers of the viral stocks on U2OS cells in which ICP0 function is
not required, thus allowing efficient replication of wild-type and all
ICP0 mutant viruses (60). We then infected HFL and NT2 cells with each virus at multiplicities based on the titers in U2OS
cells and titrated the progeny virus in U2OS cells. Increased input
multiplicities of dl1403 were used in order to initiate a
productive infection. As expected, at 36 h after infection, dl1403 replicated poorly in HFL cells compared to the
wild-type virus; even with the input virus increased 500-fold, yields
were reduced by an order of magnitude (Table 2). At the highest
multiplicity used, the yield of dl1403 was reduced by a
further order of magnitude in NT2 cells compared to HFL cells, and
extending the incubation period to 48 h did not significantly
affect the results (Table 2). Virus M1 also replicated much less
efficiently in NT2 compared to HFL cells at all multiplicities tested
(Table 2), indicating that the ability of ICP0 to bind to USP7 is
apparently very important for virus replication in NT2 cells. These
data provide the most striking indication obtained so far that the
ICP0-USP7 interaction is important for HSV-1 replication in certain
situations. As with wild-type virus (Table 1), the replication
efficiencies of the two mutant viruses in hNT cells were similar to
those in NT2 cells, with dl1403 replicating slightly less
well and M1 replicating slightly better in the differentiated cells
(Table 2).
Viral gene expression is abnormal in NT2 and hNT cells.
To
investigate the basis of the poor growth of HSV-1 in NT2 and hNT cells,
we compared viral gene expression in the two cell types with that in
the fully permissive HFL cells. Whole-cell extracts were prepared at
various times after infection and probed with a mixture of antibodies
recognizing representative IE and early gene products; we probed for
ICP0, ICP4, the large subunit of ribonucleotide reductase UL39 (ICP6),
the major DNA-binding protein UL29 (ICP8), and the DNA polymerase
accessory factor UL42. It should be noted that, because of the varied
antibody sensitivities, this Western blot approach compares the
relative expression of this group of proteins in the different samples
rather than measuring absolute protein levels. At a multiplicity of
infection of 5 there was, as might be expected on the basis of the
titration data, little difference in the patterns and time course of
viral gene expression in HFL and NT2 cells (Fig.
4A). However, reduction of the
multiplicity to 1 PFU per cell revealed an intriguing phenotype. At
2 h postinfection, some UL29 expression was detectable in HFL cells, but viral gene expression in NT2 cells was restricted to ICP0
(Fig. 4B). At 3 h UL29 and UL39 expression was well marked in HFL
cells but, compared to the expression of ICP0, was much reduced in NT2
cells. By 4 h the early viral gene products accumulated in NT2
cells, but their expression levels compared to ICP0 were still reduced
from those seen in HFL cells. These effects were more pronounced at a
multiplicity of infection of 0.2 (Fig. 4C). In hNT cells, even at
4 h after infection with a multiplicity of 5, the expression of
UL29 and UL39 was only just detectable (Fig. 4A). Since ICP0 is
expressed with greater or equivalent efficiency in NT2 and hNT compared
to HFL cells, these data suggest that the virus is entering NT2 and hNT
cells but that the infection progresses from the IE to later stages
inefficiently.

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 4.
Comparison of the rates of viral gene expression in HFL,
NT2, and differentiated hNT cells. Cells were infected with 5 (A), 1 (B), or 0.2 (C) PFU of wild-type HSV-1 strain 17+ per cell and
harvested before infection (lanes m) and at 1, 2, 3, and 4 h after
absorption (hpa) and then processed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and Western blot analysis. A
mixture of antibodies recognizing several viral proteins
was employed to detect IE proteins ICP0 and ICP4 and also the early
genes UL39, UL29, and UL42 (as indicated on the left).
|
|
The results were supported by immunofluorescence analysis of infected
HFL, NT2, and hNT cells. At 8 h postinfection, most
infected HFL
cells express abundant UL29, whereas in NT2 cells
(seeded at a higher
density in this example) few of the cells
had progressed to this stage
of infection (Fig.
5). At this time
point, none of the infected hNT cells expressing ICP0 were expressing
detectable levels of UL29 (Fig.
5).

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 5.
Inefficient progression of viral infection in NT2 and
hNT cells. HFL (top panels), NT2 (middle panels), and hNT (bottom
panels) cells were infected with wild-type HSV stain 17+ at 1 PFU per
cell. Infected cells were fixed 8 h after absorption and prepared
for immunofluorescence and simultaneous staining for ICP0 (lefthand
panels) and UL29 (righthand panels), using MAb 11060 and serum r515 as
markers of viral IE and E gene expression. In hNT cells, the number of
infected cells expressing ICP0 and UL29 is much less than in HFL and
NT2 cells. The number of NT2 cells expressing ICP0 is equivalent to the
HFL infections, but relatively few NT2 cells are expressing large
amounts of UL29.
|
|
The efficient expression of ICP0 but not of other viral polypeptides in
NT2 and hNT cells suggests that the activation of
gene expression
induced by ICP0 is compromised. It is conceivable
that one factor in
the poor growth of HSV-1 in these cells is
that ICP0 is unable to
function normally. Therefore, we designed
further experiments to test
this
possibility.
ICP0 affects ND10 and centromeres more slowly in NT2 cells than in
HFL cells.
ICP0 causes major effects on the cell by inducing the
degradation of PML, Sp100, and CENP-C, thereby disrupting both ND10 and
centromeres (12). We therefore compared the efficiency by which ICP0 induced these effects in HFL, NT2, and hNT cells. Cells were
infected with HSV-1 17+ at a multiplicity of 1 and then stained for
ICP0 and the cellular proteins PML, CENP-C, and hDaxx at various times
postinfection. In the early stages of infection, ICP0 colocalized with
PML in all cell types, but as time progressed the rate at which the PML
foci were disrupted in NT2 and hNT cells was noticeably slower than in
HFL cells (Fig. 6 and Table
3). In this experiment, only 4% of
infected HFL cells retained PML foci by 2 h postinfection, whereas
56% of NT2 cells did so. Even by 4 h postinfection, 54% of
infected NT2 cells retained punctate PML staining (Table 3). Similar
results were obtained in infected cells stained for CENP-C (Fig. 6 and
Table 3) and hDaxx (Table 3). Loss of CENP-C from centromeres in
infected HFL cells was extremely rapid, but in NT2 cells ICP0 markedly
colocalized with CENP-C at early times of infection to a greater degree
than in any other cell type we have studied (Fig. 6). It is intriguing
that ICP0 associates so well with centromeres in this cell type, in
which PML is poorly expressed and less well modified by SUMO-1 (Fig. 2)
and in which hDaxx becomes more highly associated with centromeres than
with ND10 (Fig. 1B). This suggests that ICP0 associates with a factor which can be present in both structures but is predominantly associated with centromeres in NT2 cells. At later times of infection, although about two-thirds of infected NT2 cells had lost CENP-C from centromeres (Table 3), in the remaining one-third ICP0 either remained at centromeres and CENP-C was much less completely degraded or ICP0 became
more diffuse yet CENP-C remained in characteristic centromeric foci
(Fig. 6). The results in hNT cells were similar to those in NT2 cells,
except that with the increased expression of PML and its modification
by SUMO-1 in hNT cells (Fig. 2), ICP0 strongly colocalized with PML yet
inefficiently disrupted ND10 (Fig. 6). Correspondingly, ICP0
colocalized with centromeres less efficiently in hNT cells and again
caused their disruption inefficiently (Fig. 6).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 6.
Comparison of the stability of ND10 and centromeres in
HFL, NT2, and hNT cells at 2 and 4 h after the start of infection. HFL
(top panels), NT2 (middle panels), and hNT (bottom panels) cells were
infected with wild-type HSV stain 17+ at 1 PFU per cell. After various
times of infection, cells were fixed and stained for ICP0 (MAb 11060)
and PML (r8) (lefthand pairs of panels) or ICP0 and CENP-C (r554)
(righthand pairs of panels). Both ND10 and centromeres, as judged by
PML and CENP-C staining, are more stable in infected NT2 and hNT than
in HFL cells.
|
|
These results are consistent with either of the following hypotheses:
either ICP0 activity is compromised in NT2 and hNT cells,
so that it
affects ND10 proteins more slowly and this correlates
with less
efficient infection or ICP0 stimulates viral gene expression
and
infection less efficiently, causing reduced effects on the
ND10
proteins. Either way, it appears that ICP0 functions less
efficiently
in NT2 and hNT cells. Since it has been shown that
ICP0 alone can
disrupt ND10 and induce the degradation of PML
(
17,
39,
40), the former explanation seems the more
likely.
Evidence that ICP0 activates gene expression poorly in NT2
cells.
To obtain more direct evidence that ICP0 activates gene
expression less efficiently in NT2 cells, we assessed the activation of
gene expression induced by HSV-1 IE proteins in transfected cells.
Because HFL cells transfect very poorly, we compared the results using
Vero and NT2 cells. Initially, we optimized the amount of pSS80 (a
reporter plasmid containing the ICP6 promoter linked to the CAT gene)
required to give low levels of basal activity, and then we
cotransfected the cells with increasing amounts of the ICP0 expression
vector pCI-rtag-cICP0. In Vero cells, maximal activation was obtained
using 5 to 50 ng of pCI-rtag-cICP0, while higher amounts had less
effect (Fig. 7). However, in NT2 cells pCI-rtag-ICP0 did not give any significant activation of gene expression (Fig. 7). Although Western blotting of the extracts showed
that ICP0 was slightly less well expressed in NT2 cells, 20 ng of
pCI-rtag-ICP0 in NT2 cells gave greater expression of ICP0 than 5 ng in
Vero cells, yet it failed to activate gene expression (Fig. 7).

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 7.
Comparison of the transactivation of an ICP6 expression
cassette by ICP0 in NT2 and HFL cells. Cells were cotransfected with
reporter plasmid pSS80 (ICP6 promoter linked to the CAT gene) and the
indicated amounts of the ICP0 expression plasmid pCI-rtag-cICP0 (see
Materials and Methods). The Western blot analysis of the total cell
proteins of samples transfected in parallel with the same amount of
plasmid and probed for ICP0 is shown below. The results of this single
experiment were reproduced on several independent occasions, and
similar results were obtained with a reporter containing the
glycoprotein gD promoter.
|
|
Since ICP0 and ICP4 have been shown to activate gene expression
synergistically in some situations (
14), we compared the
activation of gene expression induced by ICP4 and the combination
of
ICP4 and ICP0 in transfected cells. Again, we found that both
ICP4 and,
particularly, the ICP4-ICP0 combination were poor activators
of gene
expression in transfected NT2 cells compared to Vero cells
(data not
shown). Western blotting showed that ICP4 was less well
expressed in
NT2 cells, but this could not by itself explain the
poor activation of
gene expression observed. Thus, the reduced
activation of viral gene
expression seen in NT2 cells (Fig.
4)
could be in part a consequence of
reduced activity of both ICP0
and
ICP4.
These transfection experiments suggest that ICP0 and ICP4 are poor
activators of gene expression in NT2 cells, but a number
of factors
need to be considered. Previous studies have suggested
that HSV-1 IE
proteins are poorly expressed in neuroblastoma cells
because Oct-1, a
factor required for basal and VP16-activated
IE promoter activation, is
less abundantly expressed than the
related repressive Oct-2 factors
(
33,
34). This cannot explain
our current results since
ICP0 and ICP4 are expressed from the
HCMV or simian virus 40 SV40
promoter-enhancer regions in our
plasmids. In addition, the results
cannot be explained by intrinsic
poor transfection of NT2 cells since
similar HCMV enhancer plasmids
expressing control proteins PML and
SUMO-1 gave at least 30% of
positive transfected NT2 cells as
estimated by immunofluorescence,
and similar amounts of these proteins
were expressed in transfected
NT2 compared to Vero cells as detected by
Western blotting (data
not
shown).
Low-multiplicity infection of NT2 and hNT cells produces
quiescently infected cells which can be reactivated by ICP0 expressed
by a superinfecting virus.
Previous studies have shown that
infection by ICP0 mutant viruses can result in the maintenance of
quiescent genomes in nonproductively infected cells and that these
genomes can be reactivated by later expression of exogenous ICP0
(46). The poor infection of NT2 cells by both wild-type
and ICP0 mutant viruses and the apparently poor function of ICP0 in NT2
cells suggests that a similar situation could be occurring in these
cells. Recent studies of this type have used heavily defective viruses
to reduce the initial viral infectivity as much as possible, but the
very poor growth of dl1403 on NT2 cells allowed the
examination of quiescent infection with dl1403/lacZ, a
relatively viable virus which carries a lacZ gene driven by
the HCMV promoter and the dl1403 ICP0 deletion.
NT2 cells were infected with
dl1403/lacZ at a multiplicity
of 0.02 PFU per cell (BHK cell titer) and then maintained for 2
days at
37°C. Except for the occasional plaque of replicating
virus, indirect
immunofluorescence staining showed that the cells
in the monolayer did
not express

-galactosidase: the HCMV promoter
was inactive. The
cultures were then superinfected at 38.5°C with
3 PFU per cell of
wild-type HSV-1 strain 17+, ICP0 RING finger
deletion mutant FXE, ICP4
mutant
tsK, or the ICP4
tsK-ICP0 double
mutant
in1330 and then stained for

-galactosidase expression
8 h later. A similar experiment was conducted with hNT cells,
except that they were stained 16 h after superinfection because
of
the relatively poor growth of strain 17+ in these cells (Table
1). The
results (Fig.
8) showed that
superinfection with both
17+ and
tsK
caused the expression of

-galactosidase as a result
of reactivation
of the quiescent HCMV promoter in the initially
infecting virus. The
equivalent ICP0-deficient viruses FXE and
in1330 were unable
to reactivate the quiescent virus efficiently,
thus demonstrating that
ICP0 is required for this effect. The
addition of the proteasome
inhibitor MG132 to the reactivation
experiment demonstrated that, as in
a previous study (
19), this
activity of ICP0 requires an
active proteasome degradation pathway
(Fig.
8).

View larger version (79K):
[in this window]
[in a new window]
|
FIG. 8.
Establishment of quiescently infected NT2 and hNT
cells using an ICP0-deficient virus and reactivation by superinfecting
ICP0-positive virus. Cells were infected as described in Materials and
Methods. NT2 (upper field) and hNT (lower field) cells were initially
infected with dl1403/lacZ virus and then superinfected with
HSV-1 strain 17+ (A), tsK (B), FXE (C), in1330
(D), 17+ in the presence of MG132 (E), or else were mock infected (F).
NT2 and hNT cells were fixed 8 and 16 h postsuperinfection,
respectively, and then stained for -galactosidase expression by
immunofluorescence. Quiescent virus can be reactivated by viruses
expressing functional ICP0 viruses (A and B) but not by ICP0-deficient
viruses (C and D) or if the ICP0 activity is inhibited by MG132 (E).
|
|
 |
DISCUSSION |
In this study we have compared the expression and distribution of
selected ND10 proteins in human fibroblast HFL, neuronal precursor NT2,
and differentiated neuron-like hNT cells and then compared their
infection by HSV-1 and the functionality of ICP0 in the three
situations. We found striking differences in ND10 structure between HFL
and NT2 cells and further substantial changes in the differentiated hNT
cells. Both NT2 and hNT cells were poor hosts for HSV-1 replication,
particularly in low-multiplicity infections, and the data suggest that
a contributing factor to this poor growth could be the apparently poor
functionality of ICP0 in both cell types.
Our results demonstrating negligible expression of Sp100 and low-level
expression of PML in NT2 cells correlate well with previous studies
(27, 32), but we have extended the previous data by
demonstrating highly aberrant PML track structures in many NT2 and hNT
cells and a relatively low proportion of SUMO-1-modified PML in NT2
compared to HFL cells. Differentiation of NT2 into nondividing hNT
cells resulted in massive increases in the expression of both PML and
Sp100, which correlated with the establishment of prominent ND10 foci
in which the two proteins strongly colocalized. Since this effect
occurred only after several weeks of ATRA treatment, it is likely that
it is in some way associated with the process of differentiation rather
than with the ATRA treatment itself. This notion is consistent with the
presence of low numbers of cells in NT2 populations which express high
levels of Sp100, which are probably in the process of spontaneously differentiating.
Previous studies using cultured cells with neuronal features for HSV-1
infection have concentrated on rodent cell lines such as mouse C1300
neuroblastoma cells and derivatives (28, 29) or cells
derived from rat PC12 cells (47, 56). Similar to our
present results, these rodent cell lines were found to be poor hosts
for HSV-1 infection in low-multiplicity infections. The advantage of
the human NT2 and hNT cells is that it is possible to correlate the
efficiency of viral infection with the effects of ICP0 on ND10 and
centromeres since most available antibodies against components of these
structures recognize the human but not the equivalent rodent proteins.
We found that despite early expression of ICP0 in NT2 and hNT cells,
the progression of viral gene expression into the pattern
characteristic of lytic infection was delayed. This correlated with
relatively slow disruption of ND10, prolonged and striking association
of ICP0 with centromeres (in NT2 cells), and inefficient induced loss
of centromere protein CENP-C. It is unlikely that these effects are a
nonspecific consequence of the generally poor infection because ICP0
can disrupt ND10 and centromeres in the absence of other viral
proteins. Indeed, the observations that ICP0 is relatively abundantly
expressed in NT2 cells, as detected by Western blotting, and the slow
disruption of ND10 and centromeres in cells that are clearly expressing
ICP0 suggests that ICP0 function itself may be compromised in these cells. This contention is supported by the transfection experiments which suggest that ICP0 is a poor activator of gene expression in NT2 cells.
Our results are also relevant to the debate on whether the degradation
of ND10 proteins PML and Sp100 specifically contributes to ICP0
function or whether it is the process by which this degradation occurs
which is important. Although NT2 cells express relatively low levels of
PML and no detectable Sp100, while hNT cells express hugely increased
amounts of both proteins, hNT cells are only slightly less permissive
for HSV-1 infection than are NT2 cells. While many other factors may be
affecting the efficiency of viral replication in these two cell types,
it is clear that the endogenous expression levels of PML and Sp100 are
not dominant factors.
The replication efficiency of ICP0-deficient viruses is known to be
very dependent on cell type, such that the probability of an ICP0
mutant establishing a lytic infection in HFL cells is reduced about
2,000-fold in HFL cells compared to U2OS cells (13, 60).
NT2 and hNT cells are even more resistant than HFL cells to productive
infection by dl1403 (Table 2). It is noteworthy that the
poor growth of dl1403 in NT2 and hNT cells is not a trivial consequence of failure of the virus to enter the cells since, in a
manner analogous to the establishment of quiescent infection in
cultured cells using multiply defective viral genomes (45, 50), at least a proportion of the input dl1403
genomes can be reactivated by superinfection with viruses expressing
ICP0. A potential application of these findings could be to investigate the control of gene expression from quiescent viral genomes in cultured
human cells with neuronal characteristics.
We have shown that cultured human cells with neuronal characteristics
are poor hosts for productive HSV-1 infection in a way that correlates
at least in part with poor ICP0 functionality. Cells infected at a low
multiplicity progress inefficiently into the lytic cycle, and in the
absence of ICP0 many cells become quiescently infected. It is an
interesting speculation that, if these observations hold true in human
neuronal cells in vivo, a controlling factor in the establishment of
latent infections in neurons in natural infections could be the
relative activity of ICP0 in these cells.
 |
ACKNOWLEDGMENTS |
We thank Duncan McGeoch and Chris Preston for helpful comments on
the manuscript. We also thank Chris Preston for providing the multiply
defective HSV-1 strains and for advice on the establishment of
quiescently infected cultures. Paul Freemont, Roel van Driel, Thomas
Sternsdorf, Ann Pluta, Bill Earnshaw, and Howard Marsden kindly
provided antibodies for use in these studies.
Work in the laboratory of R.D.E. is funded by the Medical Research
Council; W.-L.H. was supported by a Glasgow University Overseas
Research Student Scholarship.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: MRC Virology
Unit, Church Street, Glasgow G11 5JR, Scotland, United Kingdom. Phone: (141) 330-3923. Fax: (141) 337-2236. E-mail:
r.everett{at}vir.gla.ac.uk.
 |
REFERENCES |
| 1.
|
Ash, R. J.
1986.
Butyrate-induced reversal of herpes simplex virus restriction in neuroblastoma cells.
Virology
155:584-592[CrossRef][Medline].
|
| 2.
|
Block, T.,
S. Barney,
J. Masonis,
J. Maggioncalda,
T. Valyi-Nagy, and N. W. Fraser.
1994.
Long term herpes simplex virus type 1 infection of nerve growth factor-treated PC12 cells.
J. Gen. Virol.
75:2481-2487[Abstract/Free Full Text].
|
| 3.
|
Boddy, M. N.,
K. Howe,
L. D. Etkin,
E. Solomon, and P. S. Freemont.
1996.
PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
Oncogene
13:971-982[Medline].
|
| 4.
|
Chatterjee, S.,
P. Burns, and J. Koga.
1995.
Effect of protein kinase C inhibitors on the antiviral activity of human alpha interferon in herpes simplex virus-infected human neuroblastoma cells.
J. Virol.
69:1315-1318[Abstract].
|
| 5.
|
Chou, J., and B. Roizman.
1992.
The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells.
Proc. Natl. Acad. Sci. USA
89:3266-3270[Abstract/Free Full Text].
|
| 6.
|
Conner, J.,
J. Murray,
A. Cross,
J. B. Clements, and H. S. Marsden.
1995.
Intracellular localisation of herpes simplex virus type 1 ribonucleotide reductase subunits during infection of cultured cells.
Virology
213:615-623[CrossRef][Medline].
|
| 7.
|
Earnshaw, W. C., and N. Rothfield.
1985.
Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma.
Chromosoma
91:313-321[CrossRef][Medline].
|
| 8.
|
Everett, R. D.
1986.
The products of herpes simplex virus type 1 (HSV-1) immediate early genes 1, 2 and 3 can activate HSV-1 gene expression in trans.
J. Gen. Virol.
67:2507-2513[Abstract/Free Full Text].
|
| 9.
|
Everett, R. D.
1987.
A detailed mutational analysis of Vmw110, a trans-acting transcriptional activator encoded by herpes simplex virus type 1.
EMBO J.
6:2069-2076[Medline].
|
| 10.
|
Everett, R. D.
1989.
Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1.
J. Gen. Virol.
70:1185-1202[Abstract/Free Full Text].
|
| 11.
|
Everett, R. D.
1999.
A surprising role for the proteasome in the regulation of herpesvirus infection.
Trends Biochem. Sci.
24:293-295[CrossRef][Medline].
|
| 12.
|
Everett, R. D.
2000.
ICP0 a regulator of herpes simplex virus lytic and latent infection.
Bioessays
22:761-770[CrossRef][Medline].
|
| 13.
|
Everett, R. D.
2000.
ICP0 induces the accumulation of co-localizing conjugated ubiquitin.
J. Virol.
74:9994-10005[Abstract/Free Full Text].
|
| 14.
|
Everett, R. D.,
C. M. Preston, and N. D. Stow.
1991.
Functional and genetic analysis of the role of Vmw110 in herpes simplex virus replication, p. 50-76.
In
E. K. Wagner (ed.), The control of herpes virus gene expression. CRC Press, Inc., Boca Raton, Fla.
|
| 15.
|
Everett, R.,
A. Cross,
J. Tyler, and A. Orr.
1993.
An epitope within the DNA-binding domain of the herpes simplex virus immediate early protein Vmw175 is conserved in the varicella-zoster virus gene 62 protein.
J. Gen. Virol.
74:1955-1958[Abstract/Free Full Text].
|
| 16.
|
Everett, R. D.,
A. Cross, and A. Orr.
1993.
A truncated form of herpes simplex virus type 1 immediate-early protein Vmw110 is expressed in a cell type dependent manner.
Virology
197:751-756[CrossRef][Medline].
|
| 17.
|
Everett, R. D., and G. G. Maul.
1994.
HSV-1 immediate-early protein Vmw110 causes redistribution of PML.
EMBO J.
13:5062-5069[Medline].
|
| 18.
|
Everett, R.,
P. O'Hare,
D. O'Rourke,
P. Barlow, and A. Orr.
1995.
Point mutations in the herpes simplex virus type 1 Vmw110 RING finger helix affect activation of gene expression, viral growth, and interaction with PML-containing nuclear structures.
J. Virol.
69:7339-7344[Abstract].
|
| 19.
|
Everett, R. D.,
A. Orr, and C. M. Preston.
1998.
A viral activator of gene expression functions via the ubiquitin-proteasome pathway.
EMBO J.
17:7161-7169[CrossRef][Medline].
|
| 20.
|
Everett, R. D.,
P. Freemont,
H. Saitoh,
M. Dasso,
A. Orr,
M. Kathoria, and J. Parkinson.
1998.
The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms.
J Virol.
72:6581-6591[Abstract/Free Full Text].
|
| 21.
|
Everett, R. D.,
M. Meredith, and A. Orr.
1999.
The ability of herpes simplex virus type 1 immediate-early protein Vmw110 to bind to a ubiquitin-specific protease contributes to its roles in the activation of gene expression and stimulation of virus replication.
J. Virol.
73:417-426[Abstract/Free Full Text].
|
| 22.
|
Everett, R. D.,
W. C. Earnshaw,
A. F. Pluta,
T. Sternsdorf,
A. M. Ainsztein,
M. Carmena,
S. Ruchaud,
W. L. Hsu, and A. Orr.
1999.
A dynamic connection between centromeres and ND10 proteins.
J. Cell Sci.
112:3443-3454[Abstract].
|
| 23.
|
Fields, B. N.,
D. M. Knipe, and P. M. Howley (ed.).
1996.
Fields virology, 3rd ed., vol. 2.
Lippincott-Raven, Philadelphia, Pa.
|
| 24.
|
Hagmann, M.,
O. Georgiev,
W. Schaffner, and P. Douville.
1995.
Transcription factors interacting with herpes simplex virus alpha gene promoters in sensory neurons.
Nucleic Acids Res.
23:4978-4985[Abstract/Free Full Text].
|
| 25.
|
Homer, E. G.,
A. Rinaldi,
M. J. Nicholl, and C. M. Preston.
1999.
Activation of herpesvirus gene expression by the human cytomegalovirus protein pp71.
J. Virol.
73:8512-8518[Abstract/Free Full Text].
|
| 26.
|
Ishov, A. M., and G. G. Maul.
1996.
The periphery of nuclear domain 10 (ND10) as sites of DNA virus deposition.
J. Cell Biol.
134:815-826[Abstract/Free Full Text].
|
| 27.
|
Ishov, A. M.,
A. G. Sotnikov,
D. Negorev,
O. V. Vladimirova,
N. Neff,
T. Kamitani,
E. T. Yeh,
J. F. Strauss III, and G. G. Maul.
1999.
PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1.
J. Cell Biol.
147:221-234[Abstract/Free Full Text].
|
| 28.
|
Kemp, L. M., and D. S. Latchman.
1989.
Regulated transcription of herpes simplex virus immediate-early genes in neuroblastoma cells.
Virology
171:607-610[CrossRef][Medline].
|
| 29.
|
Kemp, L. M.,
I. H. Gelman,
S. J. Silverstein, and D. S. Latchman.
1990.
Regulation of herpes simplex virus immediate-early gene promoters in mouse neuroblastoma cells.
Neurosci. Lett.
118:185-188[CrossRef][Medline].
|
| 30.
|
Kesari, S.,
B. P. Randazzo,
T. Valyi-Nagy,
Q. S. Huang,
S. M. Brown,
A. R. MacLean,
V. M. Lee,
J. Q. Trojanowski, and N. W. Fraser.
1995.
Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant.
Lab. Investig.
73:636-648[Medline].
|
| 31.
|
Kondo, Y.,
Y. Yura,
H. Iga,
T. Yanagawa,
H. Yoshida,
N. Furumoto, and M. Sato.
1990.
Effect of hexamethylene bisacetamide and cyclosporin A on recovery of herpes simplex virus type 2 from the in vitro model of latency in a human neuroblastoma cell line.
Cancer Res.
50:7852-7857[Abstract/Free Full Text].
|
| 32.
|
Li, H.,
C. Leo,
J. Zhu,
X. Wu,
J. O'Neil,
E. J. Park, and J. D. Chen.
2000.
Sequestration and inhibition of Daxx-mediated transcriptional repression by PML.
Mol. Cell. Biol.
20:1784-1796[Abstract/Free Full Text].
|
| 33.
|
Lillycrop, K. A.,
C. L. Dent,
S. C. Wheatley,
M. N. Beech,
N. N. Ninkina,
J. N. Wood, and D. S. Latchman.
1991.
The octamer-binding protein Oct-2 represses HSV immediate-early genes in cell lines derived from latently infectable sensory neurons.
Neuron
7:381-390[CrossRef][Medline].
|
| 34.
|
Lillycrop, K. A.,
J. K. Estridge, and D. S. Latchman.
1993.
The octamer binding protein Oct-2 inhibits transactivation of the herpes simplex virus immediate-early genes by the virion protein Vmw65.
Virology
196:888-891[CrossRef][Medline].
|
| 35.
|
Marsden, H. S.,
A. M. Cross,
G. J. Francis,
A. H. Patel,
K. MacEachran,
M. Murphy,
G. McVey,
D. Haydon,
A. Abbotts, and N. D. Stow.
1996.
The herpes simplex virus type 1 UL8 protein influences the intracellular localization of the UL52 but not the ICP8 or POL replication proteins in virus-infected cells.
J. Gen. Virol.
77:2241-2249[Abstract/Free Full Text].
|
| 36.
|
Maul, G. G.,
A. M. Ishov, and R. D. Everett.
1996.
Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1.
Virology
217:67-75[CrossRef][Medline].
|
| 37.
|
Maul, G. G.
1998.
Nuclear domain 10, the site of DNA virus transcription and replication.
Bioessays
20:660-667[CrossRef][Medline].
|
| 38.
|
Maul, G. G.,
D. Negorev,
P. Bell, and A. M. Ishov.
2000.
Review: properties and assembly mechanisms of ND10, PML bodies, or PODs.
J. Struct. Biol.
129:278-287[CrossRef][Medline].
|
| 39.
|
Muller, S., and A. Dejean.
1999.
Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption.
J. Virol.
73:5137-5143[Abstract/Free Full Text].
|
| 40.
|
Parkinson, J., and R. Everett.
2000.
Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins.
J. Virol.
74:10006-10017[Abstract/Free Full Text].
|
| 41.
|
Pleasure, S. J.,
C. Page, and V. M. Lee.
1992.
Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons.
J. Neurosci.
12:1802-1815[Abstract].
|
| 42.
|
Pleasure, S. J., and V. M. Lee.
1993.
NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell.
J. Neurosci. Res.
35:585-602[CrossRef][Medline].
|
| 43.
|
Pluta, A. F.,
W. C. Earnshaw, and I. G. Goldberg.
1998.
Interphase-specific association of intrinsic centromere protein CENP-C with HDaxx, a death domain-binding protein implicated in Fas-mediated cell death.
J. Cell Sci.
111:2029-2041[Abstract].
|
| 44.
|
Preston, C. M.
1979.
Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK.
J. Virol.
29:275-284[Abstract/Free Full Text].
|
| 45.
|
Preston, C. M., and M. J. Nicholl.
1997.
Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis.
J. Virol.
71:7807-7813[Abstract].
|
| 46.
|
Preston, C. M.
2000.
Repression of viral transcription during herpes simplex virus latency.
J. Gen. Virol.
81:1-19[Free Full Text].
|
| 47.
|
Ralph, W. M., Jr.,
M. S. Cabatingan, and P. A. Schaffer.
1994.
Induction of herpes simplex virus type 1 immediate-early gene expression by a cellular activity expressed in Vero and NB41A3 cells after growth arrest-release.
J. Virol.
68:6871-6882[Abstract/Free Full Text].
|
| 48.
|
Saitoh, H.,
J. Tomkiel,
C. A. Cooke,
H. D. Ratrie,
M. Maurer,
N. F. Rothfield, and W. C. Earnshaw.
1992.
CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate.
Cell
70:115-125[CrossRef][Medline].
|
| 49.
|
Samaniego, L. A.,
L. Neiderhiser, and N. A. DeLuca.
1998.
Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins.
J. Virol.
72:3307-3320[Abstract/Free Full Text].
|
| 50.
|
Schenk, P., and H. Ludwig.
1988.
The 65 K DNA binding protein appears early in HSV-1 replication.
Arch. Virol.
102:119-123[CrossRef][Medline].
|
| 51.
|
Smith, R. L.,
J. M. Escudero, and C. L. Wilcox.
1994.
Regulation of the herpes simplex virus latency-associated transcripts during establishment of latency in sensory neurons in vitro.
Virology
202:49-60[CrossRef][Medline].
|
| 52.
|
Sternsdorf, T.,
H. H. Guldner,
C. Szostecki,
T. Grotzinger, and H. Will.
1995.
Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis.
Scand. J. Immunol.
42:257-268[CrossRef][Medline].
|
| 53.
|
Sternsdorf, T.,
T. Grotzinger,
K. Jensen, and H. Will.
1997.
Nuclear dots: actors on many stages.
Immunobiology
198:307-331[Medline].
|
| 54.
|
Stow, N. D., and E. C. Stow.
1986.
Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110.
J. Gen. Virol.
67:2571-2585[Abstract/Free Full Text].
|
| 55.
|
Stuurman, N.,
A. de Graaf,
A. Floore,
A. Josso,
B. Humbel,
L. de Jong, and R. van Driel.
1992.
A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies.
J. Cell Sci.
101:773-784[Abstract/Free Full Text].
|
| 56.
|
Su, Y. H.,
R. L. Meegalla,
R. Chowhan,
C. Cubitt,
J. E. Oakes,
R. N. Lausch,
N. W. Fraser, and T. M. Block.
1999.
Human corneal cells and other fibroblasts can stimulate the appearance of herpes simplex virus from quiescently infected PC12 cells.
J. Virol.
73:4171-4180[Abstract/Free Full Text].
|
| 57.
|
Vahlne, A., and E. Lycke.
1978.
Herpes simplex virus infection of in vitro cultured neuronal cells (mouse neuroblastoma C 1300 cells).
J. Gen. Virol.
39:321-332[Abstract/Free Full Text].
|
| 58.
|
Wagner, E. K., and D. C. Bloom.
1997.
Experimental investigation of herpes simplex virus latency.
Clin. Microbiol. Rev.
10:419-443[Abstract].
|
| 59.
|
Wilcox, C. L.,
R. L. Smith,
R. D. Everett, and D. Mysofski.
1997.
The herpes simplex virus type 1 immediate-early protein ICP0 is necessary for the efficient establishment of latent infection.
J. Virol.
71:6777-6785[Abstract].
|
| 60.
|
Yao, F., and P. A. Schaffer.
1995.
An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1.
J. Virol.
69:6249-6258[Abstract].
|
Journal of Virology, April 2001, p. 3819-3831, Vol. 75, No. 8
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.8.3819-3831.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
McMahon, R., Walsh, D.
(2008). Efficient Quiescent Infection of Normal Human Diploid Fibroblasts with Wild-Type Herpes Simplex Virus Type 1. J. Virol.
82: 10218-10230
[Abstract]
[Full Text]
-
Groves, I. J., Sinclair, J. H.
(2007). Knockdown of hDaxx in normally non-permissive undifferentiated cells does not permit human cytomegalovirus immediate-early gene expression. J. Gen. Virol.
88: 2935-2940
[Abstract]
[Full Text]
-
Tavalai, N., Papior, P., Rechter, S., Leis, M., Stamminger, T.
(2006). Evidence for a Role of the Cellular ND10 Protein PML in Mediating Intrinsic Immunity against Human Cytomegalovirus Infections.. J. Virol.
80: 8006-8018
[Abstract]
[Full Text]
-
Everett, R. D., Boutell, C., Orr, A.
(2004). Phenotype of a Herpes Simplex Virus Type 1 Mutant That Fails To Express Immediate-Early Regulatory Protein ICP0. J. Virol.
78: 1763-1774
[Abstract]
[Full Text]
-
Jackson, S. A., DeLuca, N. A.
(2003). Relationship of herpes simplex virus genome configuration to productive and persistent infections. Proc. Natl. Acad. Sci. USA
100: 7871-7876
[Abstract]
[Full Text]
-
Everett, R. D., Sourvinos, G., Orr, A.
(2003). Recruitment of Herpes Simplex Virus Type 1 Transcriptional Regulatory Protein ICP4 into Foci Juxtaposed to ND10 in Live, Infected Cells. J. Virol.
77: 3680-3689
[Abstract]
[Full Text]
-
Jones, C.
(2003). Herpes Simplex Virus Type 1 and Bovine Herpesvirus 1 Latency. Clin. Microbiol. Rev.
16: 79-95
[Abstract]
[Full Text]
-
Marshall, K. R., Rowley, K. V., Rinaldi, A., Nicholson, I. P., Ishov, A. M., Maul, G. G., Preston, C. M.
(2002). Activity and intracellular localization of the human cytomegalovirus protein pp71. J. Gen. Virol.
83: 1601-1612
[Abstract]
[Full Text]